Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans.
Fauna Bio has raised $9.0M in total funding. The most recent round was Seed. The last funding was announced in September 2021.
Fauna Bio's investors include True Ventures, National Institutes of Health, GRIDS Capital, The Longevity Fund, Lifeforce Capital.
Fauna Bio is headquartered in Berkeley, United States.
Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans.
Fauna Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fauna Bio — Funding & Investors." VCBacked, September 21, 2021, https://www.vcbacked.co/company/fauna-bio. Accessed July 20, 2026.
VCBacked. (2021). Fauna Bio — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/fauna-bio
{{cite web |title=Fauna Bio — Funding & Investors |url=https://www.vcbacked.co/company/fauna-bio |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated